Biscayne Pharmaceuticals deal

Biscayne Pharmaceuticals spun out CNS company Biscayne Neurotherapeutics Inc. (Miami, Fla.). The newco's sole asset is BIS-001, which is in development to treat refractory forms of epilepsy, includin...